Of the Field

Next Generation Dx Summit 2026

N

ext Generation Dx Summit 2026 is the premier event for decision-makers in advanced diagnostics, bringing together over 400 diagnostics professionals and more than 120 innovation-leading speakers. The event covers a wide scope across clinical and molecular diagnostics, featuring six focused tracks on breakthrough technologies, commercial strategy, and regula…

Visit the official siteRegister
40Voices
5Underwriters
0Exhibitors
0On the bill · sessions
42Companies · in total
§I

The Voices

Programmed at Next, in alphabetical order.
Alexander Baras
MD, PhD, Leon Troper Professorship in Computational Pathology, Associate Professor of Pathology, Urology, and Oncology, Director of Computational Pathology & Informatics · Sidney Kimmel Comprehensive Cancer Center
Alexander Baras, MD, PhD
Leon Troper Professorship in Computational Pathology, Associate Professor of Pathology, Urology, and Oncology, Director of Computational Pathology & Informatics · Sidney Kimmel Comprehensive Cancer Center
Anna Bergamaschi
PhD, Vice President Product R&D · ClearNote Health
Anna Bergamaschi, PhD
VP Product Development · ClearNote Health
Brian P. Carey, JD
Partner · Hogan Lovells US LLP
Christine C. Ginocchio, PhD
MT(ASCP), CMO · Qiagen
Clarisa Blattner
Senior Director, Revenue and Payor Optimization · XiFin, Inc.
Courtney H. Lias, PhD
Director, OHT7: Office of in vitro Diagnostic Devices, United States Food and Drug Administration (FDA) · FDA
Elissa Quinn
Medical Director, Cancer Screening & Early Detection · AstraZeneca
Erica Barnell
MD, PhD, Chief Medical and Science Officer · Geneoscopy
Erica Barnell, MD, PhD
Chief Medical and Science Officer · Geneoscopy
Gabriel Bien-Willner
MD, PhD, Medical Director, MolDx · Palmetto GBA LLC
Gabriel Bien-Willner, MD, PhD
Medical Dir MolDX & CMO · Palmetto GBA LLC
Ipsita G. Smolinski, MBA
Managing Director, Capitol Street; Faculty, Georgetown University · Capitol Street / Georgetown University
Jai Pandey, PhD
Head, Global Device Regulatory IVD/CDx and Digital Health · Sanofi
Jennifer Archer
Senior Director of Market Access · Artera Inc.
Jim Almas
MD, Independent Consultant; Formerly, National Medical Director · Labcorp
Jim Almas, MD
Independent Consultant; Formerly, National Medical Director · James P. Almas
Ken Bahk
PhD, CEO · HEI Partners
Ken Bahk, PhD
CEO · HEI Partners
Lokesh Agrawal
PhD, Chief (Acting), Biorepositories & Biospecimen Research · NIH NCI
Lokesh Agrawal, PhD
Chief (Acting), Biorepositories & Biospecimen Research · NIH NCI

— and 18 more, by name unsung —

§II

Underwritten By

The houses behind the program. Tiers as disclosed.
Abingdon HealthCorporate Sponsor
CytivaCorporate Support Sponsor
MeridianCorporate Sponsor
Meridian BioscienceCorporate Sponsor
TELCORCorporate Support Sponsor
Intermission
Part the Second · For the Buyer

An audience of 42 companies, parsed from the program.

42 companies in attendance.

The numbers below are derived from the speakers, sponsors, and exhibitors on this page — cross-referenced into one ledger. They are the only thing here that 10times.com cannot tell you.

01Fig. 01 — Composition of the House
0All threespeak · spons · exh
5Sponsoringsponsor only
0Exhibitingexhibitor only
37Companies Speakingspeaker only
02Fig. 02 — The Voices, by Seniority

83% of the speakers carry senior titles — C-suite, Founder, VP, or Director-level.

  • C-suite1025%
  • Founder / Owner25%
  • VP-level615%
  • Director / Head of1538%
  • Other roles718%

Of 40 on the bill · classified by free-text title

03Fig. 03 — The Heaviest in the Room
  1. 01Abingdon HealthSp·C
  2. 02CytivaSp·C
  3. 03MeridianSp·C
  4. 04Meridian BioscienceSp·C
  5. 05TELCORSp·C
  6. 06Exact Sciences/Screening2V
  7. 07Labcorp2V
  8. 08Tempus AI2V
  9. 09AdvaMedDx1V
  10. 10American Clinical Laboratory Association1V
  11. 11Artera Inc.1V
  12. 12AstraZeneca1V
  13. 13Beth Israel Deaconess Medical Center1V
  14. 14Beth Israel Deaconess Medical Center1V
04Fig. 04 — By Tier
corporate sponsor3
60% of 5
corporate support sponsor2
40% of 5